Learn how crypto shorting works, when to use it, key risks, and best practices to trade downturns and protect long-term ...

The daily structure shows Microsoft holding firmly above the 200-day EMA at $479. This level served as the final floor during ...

A drug launch is one of the most defining events in the pharma and biotech lifecycle. It marks the moment a therapy moves ...

Bitcoin (BTC) pulled back from $94,589 on Tuesday, but the bulls are striving to maintain the price above $92,000. Market ...

The city is adding 48 new units to its transitional housing inventory, and more than 100 affordable housing spaces, Mayor ...

Nebius has emerged as a $25B AI-infrastructure leader, attracting major institutional capital and high-profile strategic ...

Celiac disease represents a growing global health concern, with current management limited to lifelong adherence to a gluten-free diet—an approach often associated with compliance challenges and ...

Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines for the treatment of cancer as ...

Solana (CRYPTO:SOL) continues to dominate real blockchain usage, but Cardano's (CRYPTO:ADA) 5% bounce has briefly redirected trader attention away from a chart that still shows structural weakness.

Additionally, NDC-011, a novel drug combination developed through DR.NOAH's AI-based drug discovery platform, received Orphan Drug Designation (ODD) from the U.S. FDA in 2023 and IND approval for a ...

US equities remained relatively stable since our last report, yet a number of issues tend to tantalise the markets.

A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody ...